CytoAgents Inc.

About CytoAgents Inc.

CytoAgents is a biotechnology company focused on developing innovative treatments for Cytokine Release Syndrome (CRS), also known as Cytokine Storm, a life-threatening immune overreaction. Their mission is to transform CRS treatment and prevention through novel therapies like CTO1681, which safely modulates cytokine production to rebalance the immune system.

Products & Services

CTO1681:An orally bioavailable, steroid-sparing immunomodulator designed to treat Cytokine Release Syndrome (CRS) by downregulating over 25 CRS-inducing cytokines. It is currently in Phase 1b/2a clinical trials for CRS in patients receiving CAR T-cell therapy.

Specialties

Cytokine Release Syndrome (CRS) treatment Immunomodulation CAR T-cell therapy-related CRS Bispecific Antibody-related CRS Clinical development in oncology, dermatology, neurology, and respiratory areas

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 2250000 MR: - FA: 2.25 million FAN: 2250000	D: 2025-10-01 FD: 2025-10-01	1 investors
2	RT: Grant T: - FT: Grant	A: 2000000 MR: - FA: $2 million FAN: 2000000	D: 2024-09-25 FD: 2024-09-25	1 investors

Grant Latest

2025-10-01

$2.2M

1 investor (Pro only)

Grant 2024-09-25

$2.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Teresa Whalen

Chief Executive Officer

LinkedIn (Pro only)

R

Roy Prieb

Chief Financial Officer

A

Arthur P. Bertolino

Chief Medical Officer

S

Stanley Marks

Chairman of UPMC Hillman Cancer Center

A

Anthony McCarley

Founder and CEO of McCarley International

C

Catherine V. Mott

Founder, CEO, Managing Partner Blue Tree Capital Group

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

CytoAgents Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised